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Neuroticism is a relatively stable personality trait characterised by negative emotionality 26 
(e.g., worry, guilt) 1; twin study heritability ranges 30 to 50% 2, and SNP-based heritability 27 
ranges 6 to 15% 3-6. Increased neuroticism is associated with poorer mental and physical 28 
health 7,8, translating to high economic burden 9. Genome-wide association (GWA) studies of 29 
neuroticism have identified up to 11 genetic loci 3,4. Here we report 116 significant 30 
independent loci from a GWA of neuroticism in 329,821 UK Biobank participants; 15 of 31 
these replicated at P<.00045 in an unrelated cohort (N = 122,867). Genetic signals were 32 
enriched in neuronal genesis and differentiation pathways, and substantial genetic 33 
correlations were found between neuroticism and depressive symptoms (rg = .82, SE=.03), 34 
major depressive disorder (MDD; rg = .69, SE=.07) and subjective wellbeing (rg = -.68, 35 
SE=.03) alongside other mental health traits. These discoveries significantly advance our 36 
understanding of neuroticism and its association with MDD. 37 
Main  38 
Understanding why people differ in neuroticism will provide an important 39 
contribution to understanding people’s liability to poor mental health throughout the life 40 
course. The strong genetic correlation between neuroticism and mental health, especially 41 
anxiety and major depressive disorder 10,11, means that exploring the genetic contribution to 42 
differences in neuroticism is one way to understand more about these common and 43 
burdensome, but aetiologically intractable illnesses. In the largest GWA study of major 44 
depressive disorder (MDD; 130,664 cases vs 330,470 controls), 44 independent genetic loci 45 
were identified 12. 46 
UK Biobank has health, medical and genetic information for over 500,000 individuals 47 
aged 39-73 years from the United Kingdom, assessed between 2006 and 2010 13,14. We 48 
performed a GWA analysis of trait neuroticism in 329,821 unrelated White British adults 49 
(152,710 male (46.3%)) with high-quality genotype data (Online Methods). Neuroticism was 50 
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measured by the total score of the 12-item Eysenck Personality Questionnaire-Revised Short 51 
Form (EPQ-R-S) 15; missing item data (ranging 1.8% to 4.7%) were imputed with reference 52 
to age and sex, and individuals with greater than 4 missing items were excluded 53 
(Supplementary Note, Supplementary Table 1 and Supplementary Fig. 1). For analysis, the 54 
score was residualized for the effects of age, sex, assessment centre, genotype batch, array, 55 
and 40 genetic principal components. This score was tested against 18,485,882 bi-allelic 56 
single nucleotide polymorphism (SNP) variants, based on the Haplotype Reference 57 
Consortium panel 16, with a minor allele frequency ≥ 0.0005 and an information/imputation 58 
quality score of ≥ 0.1 under an additive model. The distribution of obtained versus expected 59 
results under the null hypothesis showed some genomic inflation, with a lambda of 1.15 60 
(quantile-quantile plot shown in Supplementary Fig. 2). Univariate linkage disequilibrium 61 
score (LDSC) regression 17 estimates indicated that 96.8% of this inflation was due to the 62 
presence of a large polygenic signal with the intercept being close to 1 (1.02, SE = .01). SNP-63 
based heritability of neuroticism was estimated at .108 (SE=.005) using LDSC. 64 
Genome-wide significance (P < 5 x 10-8) was demonstrated for 10,353 genetic 65 
variants with a further 17,668 variants at a suggestive level (P < 1 x 10-5) (Supplementary 66 
Table 2). The Manhattan plot is shown in Figure 1 and gene annotation for the significant 67 
SNPs in Supplementary Table 3. SNPs identified in previous neuroticism GWA studies were 68 
mostly significant in our sample (Supplementary Note and Supplementary Table 2) and 69 
substantial overlap with MDD SNPs (75%) and genes was found (Supplementary Note and 70 
Supplementary Table 4). The major histocompatibility complex (MHC) region has been 71 
previously linked to schizophrenia, a psychiatric comorbidity trait (including MDD) 18,19 and 72 
MDD 12. It contained 3 significant independent genetic loci associated with neuroticism, two 73 
were in genes (GABBR1, TNXB) connected with schizophrenia 20,21. The primary associated 74 
SNP, rs2021722, for schizophrenia 18, was present in our study and nominally significant (P = 75 
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9.42 x 10-5). Supplementary Figure 3 indicates the previous MHC associations in relation to 76 
our findings. 77 
116 of the significant SNPs were independent (r2 > 0.1 and within 500kb of the 78 
significant index SNP); these lead SNPs are shown in Supplementary Table 5 with the 79 
number of associated SNPs, region size, and genes within the LD interval. 73 lead SNPs were 80 
located within genes, 5 were exonic (in MSRA, NOS1, PINX1, ZCCHC14, and C12orf49) and 81 
a further 2 were coding SNPs in RPP21 (a missense mutation) and AGBL1 (synonymous), 55 82 
were intronic and 10 were noncoding RNA variants; 42 were intergenic. For the 116 83 
independent SNPs, evidence of expression quantitative trait loci (eQTL) was explored using 84 
the GTEx database, 44 were eQTLs (Supplementary Table 5). A Regulome DB score was 85 
used to identify SNPs with a likely regulatory function. 33 of the 116 SNPs were included in 86 
the Regulome DB database and 8 of these had a score < 3, indicating that they are likely to be 87 
involved in gene regulation (Supplementary Table 5). 88 
Replication of the significant association signals in UK Biobank was sought from the 89 
results of a GWA meta-analysis of neuroticism that we performed using 23andMe (N = 90 
59,206) 22 and the Genetics of Personality Consortium (GPC-2; N = 63,661) 23. Of the 10,353 91 
genome-significant SNPs in UK Biobank, 10,171 were available in the replication cohorts, 92 
and 8,774 of these increased in significance when the replication cohorts were meta-analysed 93 
with UK Biobank. This indicated a consistent direction of allelic effect (Supplementary Table 94 
6).  95 
INSERT FIGURE 1 ABOUT HERE 96 
 97 
Of the 116 independent associated SNPs, 111 were present in the replication cohort, 98 
with 51 nominally significant (P < .05; Supplementary Table 5), and 15 at a Bonferroni-99 
corrected level (P < .00045; Table 1). One of these, rs2953805, was previously associated 100 
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with morning chronotype 24, a trait relating to lower neuroticism 25 and showing allelic effects 101 
in the expected direction. The low replication rate (13.5%) at a strict corrected level reflects 102 
the finding that effect sizes are extremely small (up to .02 of a SD increase in neuroticism 103 
score per allele) and will thus require similarly large replication samples to confirm their 104 
effects. Figure 2a-c shows the regional association plot for chromosomes 8, 11 and 22 in 105 
which multiple genes were present in the associated LD region. Of the five chromosome 8 106 
loci only one lead SNP tagged a well-known inversion, previously linked to neuroticism 107 
(Supplementary Note and Supplementary Fig. 4), although associations in the broad region 108 
had been attributed to the inversion 4 and so might cautiously be considered as a single locus.  109 
All 69 genes located within the 15 replicated loci were classified in terms of their 110 
molecular function, biological process and protein class using the Protein Analysis Through 111 
Evolutionary Relationships Classification System which includes 14,710 protein families 112 
categorised into 76,032 functionally distinct subfamilies 26. Supplementary Figure 4 shows 113 
that a large number of genes 1) coded for nucleic acid binding and transcription factors, 2) 114 
contributed to metabolic and cellular processes, and 3) had a role in binding and catalytic 115 
activity molecular functioning. Transcription factors, in particular, have been implicated in 116 
the aetiology of depression 27,28, and miRNAs—which have been linked with anxiety29 and 117 
depression 30—might target genes with roles in binding (e.g., POLR3H). The PsyGeNET 118 
(v2.0) database showed that of the 69 genes, four have been associated with psychiatric 119 
disorder (Supplementary Table 7): DRD2 (bipolar, depression, substance use/dependence, 120 
delirium), EP300 (alcoholic intoxication), TEF (depression) and MSRA (schizophrenia). 121 
Variants in CACNA1E have been associated with cross-psychiatric disorder overlap and 122 
migraine 18,31. 123 
A GTEx database search for the 15 replicated SNPs showed that 9 were associated 124 
with significant regulation of 60 genes expressed in a variety of tissues (Supplementary Table 125 
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8). Of the 30 brain expression associations, half of these were in the cerebellum: 4 SNPs 126 
regulating 10 genes. Interestingly, MRI studies have shown associations between cerebellar 127 
volume and neuroticism, and cerebellar blood flow in response to negative emotional cues 128 
32,33. In the BRAINEAC search, all SNPs were identified as eQTLs in at least one brain 129 
region at a nominal significance level (P < .05) and 10 were supported at a Bonferroni-130 
corrected level of P < .0003 (Supplementary Table 9). Of potential interest, rs7107356, a 131 
novel SNP in an intergenic region of chromosome 11, regulates MTCH2 in the cerebellar 132 
cortex (P = 4.5x10-6). MTCH2 is involved in metabolic pathways and cell function 34 and 133 
variants of this gene have been associated with BMI 35. 134 
Gene-based analysis of the GWA results was performed using MAGMA 36 ; 249 135 
genes were significantly associated at a Bonferroni-corrected level (α = 0.05 / 18,080; P < 136 
2.77 × 10-6 ; Supplementary Table 10). Three of these were genes (STH, HIST1H3J, 137 
HIST1H4L) containing a single SNP. Of the replicated independent GWA SNPs that were in 138 
genes, the following significant genes were corroborated in the gene-based results: 139 
CACNA1E, XKR6, MSRA, LINGO2, CELF4, ZC3H7B and BAIAP2. SNP rs6981523, 140 
previously identified in 23andMe for neuroticism 22, was an intergenic SNP near XKR6; this 141 
gene was the second most significant gene in our gene-based analysis (P = 6.55 × 10-32). 142 
L3MBTL2 and CHADL, wherein 23andMe’s other significant SNP, rs9611519, resided, 143 
showed respective gene-based p-values of 2.40 × 10-6 and 1.15 × 10-6.  144 
Pathway analysis in MAGMA highlighted 5 significant gene ontology pathways 145 
(family-wise error P < 1.21 × 10-6): neuron spine (cellular), homophilic cell adhesion via 146 
plasma membrane adhesion molecules (biological), neuron differentiation (biological), cell 147 
cell adhesion via plasma membrane adhesion molecules (biological), and neurogenesis 148 
(biological). See Table 2 for further details. Of note is the neurogenesis pathway, a 149 
hypothesis of which exists for depression (and to a lesser extent, anxiety) based on stress 150 
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reducing neurogenesis in the hippocampus and on the action of antidepressants on brain 151 
circuitry 37,38. Further, variants in PLXNA2, potentially involved in adult neurogenesis, have 152 
been associated with anxiety and neuroticism 39. Cell adhesion molecules have been 153 
implicated in neuropsychiatric disorder 40, and protocadherins specifically with neuroticism 154 
and risk of mood disorder 41, which supports the importance of cell adhesion pathways.  A 155 
further gene-set analysis of genes expressing proteins that can bind to anti-depressant drug 156 
molecules was significant (P = .005) re-affirming the dependency of neuroticism and 157 
depression on shared biological pathways. This is consistent, for example, with findings for 158 
CRHR1 (highlighted in our SNP and gene-based analysis), a gene involved in normal 159 
hormonal responses to stress (the glucocorticoid pathway being a relevant and well-known 160 
target) and associated with anxiety, depression and neuroticism 3,42,43. That genes influencing 161 
neuroticism reveal pathways involved in currently prescribed and effective antidepressant 162 
action suggests that neuroticism could be a potentially useful clinical stratifying factor for 163 
effective antidepressant action. There may also be clinical utility in knowing a person’s level 164 
of neuroticism after the occurrence of a stressful life event and therefore pre-empting onset of 165 
depression via drug therapy in those high in neuroticism. Because our GWA of neuroticism 166 
reveals signals associated with the known biological action of existing antidepressants, it may 167 
be useful as a means of discovering (or re-purposing) new pharmacological interventions for 168 
MDD. 169 
LD score regression 44 was used to estimate the genetic correlation between 170 
neuroticism and a variety of health traits (Supplementary Tables 11 and 12). The strongest 171 
correlation was observed for depressive symptoms (rg = .82, SE = .03). Major depressive 172 
disorder, subjective wellbeing, and tiredness showed moderate-to-strong correlations (.62-173 
.69). The stronger correlation for depressive symptoms than depressive disorder might be 174 
indicative of improved sensitivity of continuous versus dichotomous traits but might also 175 
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point to inventory item overlap (greater conceptual similarity) for depressive symptoms 176 
and/or noise in MDD diagnosis. Genetic correlations with neuroticism were moderate for 177 
self-rated health (.41), moderate-to-low for schizophrenia, ADHD, anorexia nervosa and 178 
educational attainment (~|.20|), and low for bipolar disorder and smoking status (|.11|). The 179 
genetic correlation of one between Eysenck neuroticism and other neuroticism scales (used 180 
by 23andMe and the GPC) confirms that GWA meta-analysis based on different 181 
measurement instruments is valid. Mendelian randomization was used to determine whether 182 
the genetic correlation between neuroticism and non-psychiatric variables (less likely to be 183 
influenced by pleiotropy), smoking status and educational attainment, represented a causal 184 
relationship from neuroticism. For smoking status, the beta of 0.23 was significant in the 185 
inverse variance weighted model (P = .00002) which is preferred in the presence of 186 
heterogeneity (P = .001); the MR Egger regression did not show significant directional 187 
pleiotropy (intercept = 0.02, P = .10) thus supporting a causal relationship. For educational 188 
attainment, the beta of -0.09 was significant (P = 8.35 × 10-6) in the inverse variance 189 
weighted model (heterogeneity P = 5.87 × 10-7), with no evidence of directional pleiotropy 190 
(intercept = 0, P = .23). Although theoretically less plausible, the reverse causal direction 191 
should be investigated in UK Biobank once a large number of significant SNPs influencing 192 
smoking status and educational attainment have been estimated in non-overlapping samples.  193 
Polygenic profile analyses based on the SNP inclusion threshold with the optimal 194 
signal-to-noise ratio (P < .05) indicated that the neuroticism polygenic score explained 2.79% 195 
of the variance in neuroticism (β = .19, P = 2.65 × 10-47) and 0.8% of the variance in 196 
depression status (OR = 1.25, P = 1.53 × 10-8) in Generation Scotland (GS; N = 7,388) 45. 197 
Results for polygenic scores in GS based on other SNP significance inclusion thresholds 198 
(0.01, 0.05, 0.1, 0.5 and 1) from the UK Biobank GWA can be found in Supplementary Table 199 
13. 200 
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The combination, in UK Biobank, of a large ethnically homogenous sample and a 201 
well-validated neuroticism scale has afforded the discovery of 15 stringently replicated 202 
genetic loci that influence neuroticism levels, four of them novel. Most lead variants were 203 
associated with gene regulation, with half of these expressed in the brain; single variant and 204 
gene associations overlapped substantially with MDD findings, and genes in antidepressant-205 
targeted pathways were over-represented. There was also support for neuroticism having 206 
causal effects on socio-economic markers. These discoveries promise paths to understand the 207 
mechanisms whereby some people become depressed, and of broader human differences in 208 
happiness, and they are a resource for those seeking novel drug targets for major depression. 209 
After millennia in which scholars and researchers have sought the sources of individual 210 
differences in proneness to dysphoria 46, the present study adds significantly to explaining the 211 
(genetic) anatomy of melancholy. 212 
 213 
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Figure Legends for Main Text 373 
Figure 1. GWA results for neuroticism in 329,821 UK Biobank individuals. 374 
 375 
Figure 2. Regional association plot for suggestive/significant signals in UK Biobank on a) 376 
chromosome 8p (site of the inversion polymorphism), b) chromosome 11, and c) 377 
chromosome 22. The SNP association p-value is shown on the y-axis and the SNP position 378 
(with gene annotation) appears on the x-axis; for each SNP, the strength of LD with the lead 379 
SNP is colour coded based on its r2. Plots were produced in LocusZoom. 380 
  381 
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Tables 382 
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Table 1. Fifteen independent SNPs associated with neuroticism in UK Biobank most strongly replicated (with consistent allelic effect) in 383 
the meta-analysis of 23andMe and the GPC cohorts. Bolded genes were significant in the gene-based tests. 384 
Chr SNP MAF Discovery P-
value 
(N=329,821) 
Replication 
P-value 
(N=122,867) 
Nearest Gene Distance 
to Gene 
Genes within Range Significant in 
Previous GWA 
Studies 
1 rs169235 .25 3.97×10-9 
 
2.55E-05 CACNA1E** 0   
5 rs1422192^ .17 1.68×10-9 6.54E-07 LINC00461 0 MEF2C**  
8*ǂ rs2921036 .49 8.04×10-26 3.27E-07 . . CLDN23, ERI1**, MFHAS1**, 
SGK223 
 
8*ǂ rs2953805 .47 3.02×10-22 1.26E-08 U3 1292 CLDN23, ERI1**, MFHAS1**, 
PPP1R3B 
 
Morning vs 
Evening 
Chronotype 24  
8*ǂ rs6982308 .49 6.46×10-21 2.26E-08 MSRA** 0   
8*ǂ rs7005884 .45 1.92×10-23 1.34E-07 XKR6 0 C8orf74, PINX1**, PRSS55**, 
RP1L1, SOX7**, XKR6 
 
8*ǂ rs10097870 .47 2.18×10-24 6.51E-07 LINC00208 5665 BLK**, CTSB**, DEFB134**, 
DEFB135, DEFB136, 
FAM167A**, FDFT1, GATA4, 
LOC100133267, MTMR9, 
NEIL2, SLC35G5, XKR6 
 
9 rs1521732 .37 2.91×10-9 4.01E-06 LINGO2 0   
9 rs72694263 .08 2.12×10-8 0.000237 . .   
11* rs7107356 .50 1.52×10-12 1.34E-05 AGBL2 4973 ACP2, AGBL2, C1QTNF4, 
CELF1, DDB2**, FAM180B, 
FNBP4**, KBTBD4, MADD**, 
MTCH2**, MYBPC3, NDUFS3, 
NR1H3, NUP160**, PSMC3, 
PTPMT1, RAPSN, SLC39A13**, 
Neuroticism 4 
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SPI1 
11* rs7111031 .36 1.06×10-15 0.000215 . . DRD2  
15* rs7175083 .48 1.16×10-9 0.000297 LINGO1 0   
17 rs7502590 .15 2.61×10-11 0.000146 BAIAP2 0 AATK, BAIAP2 
 
 
18* rs11082011 .34 1.25×10-16 2.05E-06 CELF4 0   
22* rs11090045 .30 8.04×10-13 5.40E-07 ZC3H7B** 0 ACO2, C22orf46, CHADL, 
CSDC2**, DESI1, EP300, 
L3MBTL2**, MEI1, NHP2L1, 
PHF5A, PMM1, POLR3H, 
RANGAP1**, RBX1, TEF**, 
TOB2, XRCC6, ZC3H7B** 
 
^ Genotyped SNP 385 
ǂ Located in Inversion Region 386 
* Broad region implicated in previous studies 4,22,45  387 
** Regulated gene expressed in brain 388 
  389 
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Table 2. Significant gene ontology pathways for neuroticism in UK Biobank 390 
Pathway Number 
of genes 
Beta SE P-value Corrected P Definition 
Neuron Spine 147 0.560 0.107 7.77×10-8 0.0282 A small membranous protrusion, often ending in a 
bulbous head and attached to the neuron by a 
narrow stalk or neck. 
Homophilic Cell 
Adhesion Via Plasma 
Membrane Adhesion 
Molecules 
115 0.490 0.0938 8.81×10-8 0.0289 The attachment of a plasma membrane adhesion 
molecule in one cell to an identical molecule in an 
adjacent cell. 
Neuron Differentiation 1341 0.145 0.0288 2.36×10-7 0.0357 The process in which a relatively unspecialized 
cell acquires specialized features of a neuron. 
Cell Cell Adhesion Via 
Plasma Membrane 
Adhesion Molecules 
828 0.183 0.0364 2.72×10-7 0.0372 The attachment of one cell to another cell via 
adhesion molecules that are at least partially 
embedded in the plasma membrane. 
Neurogenesis 195 0.419 0.0859 5.35×10-7 0.0439 Generation of cells within the nervous system 
22 
 
Online Methods 391 
Genome-wide association analysis in UK Biobank 392 
An imputed dataset, including >92 million variants, referenced to the UK10K 393 
haplotype, 1000 Genomes Phase 3, and Haplotype Reference Consortium (HRC) panels was 394 
available in UK Biobank. The current analysis includes only those SNPs available in the 395 
HRC reference panel 47. Quality control filters were applied (see Supplementary Note) which 396 
resulted in 18,485,882 imputed SNPs for analysis in 329,821 individuals. The GWA of 397 
neuroticism was conducted using BGENIE 48, a program specifically developed to analyse 398 
UK Biobank data in a fast and efficient manner. Further information can be found at the 399 
following URL: https://jmarchini.org/bgenie/. A linear SNP association model was tested 400 
which accounted for genotype uncertainty. Neuroticism was pre-adjusted for age, sex, 401 
genotyping batch, genotyping array, assessment centre, and 40 principal components to speed 402 
up analysis. 403 
The number of independent signals from the GWA analysis was determined using 404 
LD-clumping in PLINK v1.90b3i 49 (see URLs). The LD structure was based on SNPs with a 405 
p-value < 1 × 10-3 that were extracted from the imputed genotypes. Index SNPs were 406 
identified (P < 5 × 10-8) and clumps were formed for SNPs with P < 1 × 10-5 that were in LD 407 
(r2 > 0.1) and within 500kb of the index SNP. SNPs were assigned to no more than one 408 
clump. 409 
 410 
Meta-analysis of GWA Results 411 
Two meta-analyses were performed. Firstly, to check for replication of the significant 412 
(P < 5 × 10-8) GWA signals in UK Biobank, results from a meta-analysis of 23andme 50 (the 413 
full GWA summary statistics were made available from 23andMe) and the Genetics of 414 
Personality Consortium (GPC-2) 51 (the full GWA summary statistics were publicly available 415 
23 
 
see URLs ) were used. This meta-analysis was conducted using METAL 52 and due to the 416 
lack of phenotype harmonisation across the cohorts, a sample size weighted meta-analysis 417 
was preferred. A second meta-analysis of UK Biobank and the replication cohorts was 418 
performed using the same method, but only for the SNPs that were significant in UK 419 
Biobank. 420 
 421 
Genome-wide Gene-based Analysis 422 
Gene-based analysis of neuroticism was performed using MAGMA 53, which 423 
provides gene-based statistics derived using the results of the GWA analysis. Genetic variants 424 
were assigned to genes based on their position according to the NCBI 37.3 build, with no 425 
additional boundary placed around the genes. This resulted in a total of 18,080 genes being 426 
analysed. The European panel of the 1000 Genomes data (phase 1, release 3) was used as a 427 
reference panel to account for linkage disequilibrium. A genome-wide significance threshold 428 
for gene-based associations was calculated using the Bonferroni method (α=0.05/18,080; P < 429 
2.77 × 10-6). 430 
 431 
Functional annotation and gene expression 432 
For the 116 independent genome-wide significant SNPs identified by LD clumping, 433 
evidence of expression quantitative trait loci (eQTL) and functional annotation were explored 434 
using publicly available online resources. The Genotype-Tissue Expression Portal (GTEx) 435 
(see URLs) was used to identify eQTLs associated with the SNPs. Functional annotation was 436 
investigated using the Regulome DB database 54 (see URLs). Further to GTEx searches, we 437 
investigated whether any of the 15 replicated SNPs were brain expression quantitative loci 438 
(eQTLs) by entering them into the brain eQTL database BRAINEAC (see URLs), which 439 
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contains gene expression data across ten brain regions (cerebellar cortex, frontal cortex, 440 
hippocampus, medulla, occipital cortex, putamen, substantia nigra, temporal cortex, thalamus 441 
and intralobular white matter). The genes located in the region of replicated independent loci 442 
were investigated for protein function using the PANTHER database (Protein ANalysis 443 
THrough Evolutionary Relationships, see URLs ) which stores data on the evolution and 444 
function of protein-coding genes from sequenced genomes of diverse species 55, our focus 445 
here on homo sapiens. Uncharacterized gene function is predicted via phylogenetic branching 446 
information and the resource enables biological pathway annotation. 447 
 448 
Pathway Analysis 449 
Biological pathway analysis was performed on the gene-based analysis results. This 450 
gene-set enrichment analysis was conducted utilising gene-annotation files from the Gene 451 
Ontology (GO) Consortium (see URLs) 56 taken from the Molecular Signatures Database 452 
(MSigDB) v5.2. The GO consortium includes gene-sets for three ontologies; molecular 453 
function, cellular components and biological function. This annotation file consisted of 5,917 454 
gene-sets which were corrected for multiple testing correction using the MAGMA default 455 
setting correcting for 10,000 permutations. 456 
To determine whether the genetic targets of antidepressants were enriched for 457 
neuroticism we performed a competitive gene-set analysis using MAGMA. Gene sets 458 
corresponding to the Anatomical Therapeutic Chemical Classification System code N06A 459 
Antidepressants (within the Psychoanaleptics class) were downloaded (see URLs). This 460 
resulted in a set of 110 unique genes corresponding to those that are the targets of the 461 
antidepressants. Enrichment for neuroticism was tested against a set of 5483 ‘druggable’ 462 
autosomal genes (see URLs), that is, they code for proteins which can bind to drug-like 463 
25 
 
molecules. Of the 110 antidepressant genes 86 were found amongst the 5483 druggable 464 
genes. 465 
 466 
Linkage Disequilibrium Score Regression 467 
Univariate Linkage disequilibrium Score (LDSC) regression 57 was used to test for 468 
residual stratification in our GWAS summary statistics and to derive a heritability estimate. 469 
An LD regression was performed by regressing the GWA test statistics (χ2) on to each SNP’s 470 
LD score (the sum of squared correlations between the minor allele frequency count of a SNP 471 
with the minor allele frequency count of every other SNP). This regression allows for the 472 
estimation of heritability from the slope, and a means to detect residual confounders, the 473 
intercept. The percentage inflation in the test statistic due to polygenic signal can be derived 474 
by subtracting the LDSC ratio ((intercept - 1)/(mean χ2 - 1)), which represents inflation due to 475 
population stratification and other confounding, from 1 and multiplying by 100. Bivariate 476 
LDSC regression 58 was used to derive genetic correlations between neuroticism and 18 477 
psychiatric and physical health phenotypes (see Supplementary Table 11). For Alzheimer’s 478 
disease, a 500-kb region surrounding APOE was excluded and the analysis re-run 479 
(Alzheimer’s disease (500kb)). The genetic correlation between neuroticism as measured by 480 
different inventories was also estimated. Further details, including source of GWA summary 481 
statistics can be found in the Supplementary Note. Sample overlap could not be controlled for 482 
in the LDSC analyses because the exact overlap between the UK Biobank data and the health 483 
traits was unknown. In such a case, constraining the intercept to a ‘wrong’ value could lead to 484 
biased estimates. Any sample overlap in the present analyses will only affect the intercept of 485 
the regression and could lead to inflated standard errors, but will not affect the genetic 486 
correlation 12. 487 
 488 
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Mendelian Randomization 489 
Two sample Mendelian Randomization (MR) was performed using the TwoSampleMR 59 490 
package implemented in R. GWA summary statistics from the GWA of smoking status in 491 
74,053 Europeans 60 was used to create outcome data for the MR between neuroticism and 492 
smoking status. 77 independent SNPs associated with neuroticism were available in the 493 
smoking status GWA summary data to test for a causal effect of neuroticism on smoking 494 
status. There were no significant SNP signals for smoking status to test the reverse causation 495 
model. GWA summary statistics from the GWA of educational attainment in 126,559 496 
Caucasians 61 was used to create outcome data for the MR between neuroticism and 497 
educational attainment. 75 independent SNPs associated with neuroticism were available in 498 
the educational attainment GWA summary data to test for a causal effect of neuroticism on 499 
educational attainment. There were too few significant SNPs available for educational 500 
attainment to test for a causal effect of educational attainment on neuroticism. Sensitivity 501 
analyses were performed to test for heterogeneity and a further test for horizontal pleiotropy 502 
was carried out.  503 
 504 
Polygenic Prediction into Generation Scotland 505 
Polygenic profile analyses were performed to predict neuroticism and depression status in 506 
Generation Scotland (GS) 62. Polygenic profiles were created in PRSice 63 using the UK 507 
Biobank neuroticism SNP-based association results, for 7,388 unrelated individuals in GS. 508 
SNPs with a MAF <0.01 were removed prior to creating the polygenic profiles. Clumping 509 
was used to obtain SNPs in linkage disequilibrium with an r2 < 0.25 within a 250kb window. 510 
Individuals were removed from GS if they had contributed to both UK Biobank and GS (n = 511 
302). Polygenic profile scores were created based on the significance of the association in 512 
UK Biobank with the neuroticism phenotype, at p-value thresholds of 0.01, 0.05, 0.1, 0.5 and 513 
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1 (all SNPs). Linear regression models were used to examine the associations between the 514 
polygenic profile and neuroticism score in GS, adjusting for age at measurement, sex and the 515 
first 10 genetic principal components to adjust for population stratification. Logistic 516 
regression models were used to examine depression status, adjusting for the same covariates 517 
as in the neuroticism models. The false discovery rate (FDR) method was used to correct for 518 
multiple testing across the polygenic profiles for neuroticism at all five thresholds 64. 519 
 520 
Data Availability 521 
The GWA results generated by this analysis are publicly available at 522 
http://www.ccace.ed.ac.uk. 523 
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